1 BTC
=
- USD
iShares U.S. Healthcare ETF
As of June 25, 2026 at 06:08 UTC
Chart
About iShares U.S. Healthcare ETF
No description available.
IYH in Bitcoin terms
iShares U.S. Healthcare ETF is available in Roxom Terminal as an ETF page for investors who want to evaluate global market exposure without leaving a Bitcoin-denominated workflow.
- ETF pages expand Roxom's searchable global-market surface beyond single companies.
- BTC-denominated charting makes the ETF comparable to Bitcoin and other assets in the terminal.
- Related market hubs help users move from a specific ETF to broader BTC-priced markets.
Market Statistics
Trading Metrics
How to Buy IYH
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy IYH
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesAbbVie reported Phase 1 study results for ABBV-295, a long-acting amylin analog for obesity treatment, showing dose-dependent weight reductions of 7.75% to 9.79% at week 12 with generally mild side effects. Despite positive drug data, AbbVie shares traded lower on Monday amid broader market pressure.
Economists have raised the probability of a U.S. recession within the next 12 months, citing a disappointing jobs report and market volatility. However, JPMorgan Chase CEO Jamie Dimon believes the U.S. economy has not entered a recession, though the odds of one are more likely than not. Investors are advised to consider defensive sectors like quality, consumer staples, healthcare, and utilities to navigate the uncertain environment.
The healthcare sector has gained momentum recently, with investors rushing to buy beaten-down stocks. The performance of major healthcare ETFs like XLV, VHT, IYH, and FHLC will depend on the upcoming earnings releases of big names like Pfizer, Merck, Amgen, AbbVie, Bristol Myers Squibb, and Eli Lilly.
